EMERYVILLE, Calif., Dec. 01, 2016 -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it has executed with its long-time partner Kuraray Co., LTD (TYO:3405) a multi-year extension to their collaboration agreement for the use of Amyris’s Biofene® branded ß-Farnesene in liquid farnesene rubber (“LFR”) and farnesene-based elastomer applications. This collaboration, which originally began in 2011, features increased farnesene supply to Kuraray and joint marketing of products to industry and end-customers.
Amyris’s sugar cane-derived Biofene forms the basis for a wide range of products varying from specialty products such as cosmetics, perfumes, detergents and industrial lubricants, to transportation fuels such as diesel and jet fuel. As a tailor made pure hydrocarbon it provides numerous advantages when compared to petroleum-based oils and chemicals and is renewable, contributing to a sustainable future.
Farnesene Fueling Better Products Across the World – Including Tires
Kuraray’s recent technological successes with rubber containing farnesene includes an enhanced synthetic additive for tire manufacturers. Its novel LFR and other farnesene- containing rubber materials add substantial grip and cornering capability to tires, particularly in cold, snow and ice conditions. In addition, its hydrogenated styrenic-farnesene copolymer (“HSFC”) has demonstrated superior shock absorption in products ranging from footwear to specialty construction materials.
“We are delighted to extend our relationship with Kuraray,” said John Melo, CEO of Amyris. “Introducing a novel molecule to industry requires patience and creativity. However, Kuraray’s technical expertise and customer relationships have reached the point where their products are now becoming mainstream and this, in turn, is fueling further broadening market adoption of our farnesene for a variety of products.”
“Kuraray has many years’ experience working with farnesene, which we believe has many end-market applications,” said Mr. Kenichi Abe, President of Kuraray’s Isoprene business. “Our collaboration with Amyris and their breakthrough-ability to produce farnesene at industrial scale, and at competitive price, enables Kuraray to provide its customers products with superior performance and that are renewably sourced.”
About Amyris
Amyris is the integrated renewable products company that is enabling the world's leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise® products across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, and pharmaceuticals and nutraceuticals. More information about the company is available at www.amyris.com.
Forward-Looking Statements
This release contains forward-looking statements, and any statements other than statements of historical facts could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events (such as market adoption of farnesene) that involve risks and uncertainties. These statements are based on management's current expectations and actual results and future events may differ materially due to risks and uncertainties, including risks related to manufacturing capacity at Amyris’s Brotas facility, delays or failures in development, production and commercialization of products, liquidity and ability to fund capital expenditures, Amyris’s reliance on third parties to achieve its goals, and other risks detailed in the “Risk Factors” section of Amyris’s quarterly report on Form 10-Q filed on November 9, 2016. Amyris disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.
Amyris, the Amyris logo and Biofene are registered trademarks of Amyris, Inc. All other trademarks are trademarks of their respective owners.
Contact: Peter DeNardo Director, Investor Relations and Corporate Communications Amyris, Inc. +1 (510) 740-7481 [email protected] [email protected]


Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
Apple Turns 50: From Garage Startup to AI Crossroads
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
First Western Ship Transits Strait of Hormuz Since Iran War Began
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding? 



